CA2172387A1 - Virus recombinant de la laryngotracheite infectieuse aviaire; applications - Google Patents

Virus recombinant de la laryngotracheite infectieuse aviaire; applications

Info

Publication number
CA2172387A1
CA2172387A1 CA002172387A CA2172387A CA2172387A1 CA 2172387 A1 CA2172387 A1 CA 2172387A1 CA 002172387 A CA002172387 A CA 002172387A CA 2172387 A CA2172387 A CA 2172387A CA 2172387 A1 CA2172387 A1 CA 2172387A1
Authority
CA
Canada
Prior art keywords
ser
leu
ala
virus
infectious laryngotracheitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002172387A
Other languages
English (en)
Inventor
Martha A. Wild
Mark D. Cochran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2172387A1 publication Critical patent/CA2172387A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Virus de recombinaison de la laryngotrachéite infectieuse (ITLV) qui sont utiles en tant que vaccins pour protéger des poulets ou d'autres espèces de volaille du virus de la laryngotrachéite infectieuse. La présente invention concerne en outre des procédés permettant de distinguer un animal vacciné à l'aide d'un vaccin de la présente invention d'un animal infecté par un virus de la laryngotrachéite infectieuse d'origine naturelle.
CA002172387A 1993-09-24 1994-09-16 Virus recombinant de la laryngotracheite infectieuse aviaire; applications Abandoned CA2172387A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12659793A 1993-09-24 1993-09-24
US08/126,597 1993-09-24

Publications (1)

Publication Number Publication Date
CA2172387A1 true CA2172387A1 (fr) 1995-03-30

Family

ID=22425710

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002172387A Abandoned CA2172387A1 (fr) 1993-09-24 1994-09-16 Virus recombinant de la laryngotracheite infectieuse aviaire; applications

Country Status (5)

Country Link
EP (1) EP0723584A4 (fr)
JP (1) JPH09505726A (fr)
AU (1) AU7838694A (fr)
CA (1) CA2172387A1 (fr)
WO (1) WO1995008622A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2946395A (en) * 1994-06-30 1996-01-25 Board of Regents of the University of Illinois, The Recombinant infectious laryngotracheitis virus and vaccine
WO1996029396A1 (fr) * 1995-03-23 1996-09-26 Syntro Corporation Virus de la laryngotracheite infectieuse recombine et ses utilisations
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US7205398B2 (en) 2002-05-24 2007-04-17 Schering-Plough Animal Health Corporation Eta-1 gene and methods for use
BR112013002525A2 (pt) * 2010-08-02 2016-05-31 Univ Georgia vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
DE68912441T2 (de) * 1988-06-24 1994-05-11 British Tech Group Nichtessentielle Geflügelpockenvirus-Regionen.
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
WO1992003554A1 (fr) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Vaccin contre le virus de la laryngotracheite infectieuse
US5279965A (en) * 1991-04-05 1994-01-18 Keeler Jr Calvin L Recombinant infectious laryngotracheitis virus

Also Published As

Publication number Publication date
EP0723584A1 (fr) 1996-07-31
JPH09505726A (ja) 1997-06-10
WO1995008622A1 (fr) 1995-03-30
EP0723584A4 (fr) 2000-12-20
AU7838694A (en) 1995-04-10

Similar Documents

Publication Publication Date Title
CA2196570C (fr) Herpesvirus recombines des dindons et leurs utilisations
US5853733A (en) Recombinant herpesvirus of turkeys and uses thereof
AU623913B2 (en) Fowlpox virus non-essential regions
US7892564B2 (en) Recombinant infectious laryngotracheitis virus and uses thereof
EP0914458A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US5741696A (en) Recombinant equine herpesviruses
EP0644931A1 (fr) Virus de l'herpes des gallinaces type 2 recombine et ses utilisations
US5961982A (en) Recombinant herpesvirus of turkeys and uses thereof
US5731188A (en) Recombinant equine herpesviruses
CA2172387A1 (fr) Virus recombinant de la laryngotracheite infectieuse aviaire; applications
CA2216139C (fr) Virus de la laryngotracheite infectieuse recombine et ses utilisations
JP3529134B2 (ja) 組換えネコヘルペスウイルスのベクターワクチン
EP0654089B1 (fr) Virus de l'herpes equin recombinant
US6225111B1 (en) Recombinant equine herpesviruses
CA2626498C (fr) Virus recombinant chimerique
AU750084B2 (en) Recombinant herpesvirus of turkeys and uses thereof II
AU684046C (en) Recombinant herpesvirus of turkeys and uses thereof
AU6250500A (en) Recombinant infectious laryngotracheitis virus and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued